Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2012

01.04.2012 | Maternal-Fetal Medicine

Induction of labor in prolonged pregnancy with unfavorable cervix: comparison of sequential intracervical Foley catheter–intravaginal misoprostol and intravaginal misoprostol alone

verfasst von: A. Babatunde Ande, C. Michael Ezeanochie, N. Biodun Olagbuji

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the outcome of induced labor at term using sequential intracervical Foley catheter with intravaginal misoprostol versus intravaginal misoprostol alone.

Methods

A prospective matched case control study among parturient with prolonged pregnancy and unfavorable cervix at a tertiary hospital in Nigeria.

Results

The study population was 100 with a mean age of 29.46 ± 3.88 years. Parturient with prior cervical priming using intracervical Foley catheter had significantly lower oxytocin augmentation of uterine contractions in labor (44 vs. 64%, P = 0.045), shorter mean insertion to active phase labor duration (233 ± 98 vs. 354 ± 154 min, P = 0.0001), shorter insertion to delivery interval (514 ± 175 vs. 627 ± 268, P = 0.014), more vaginal delivery <12 h (92.5 vs. 60%, P = 0.001) and less delivery by caesarean section (20 vs. 40%, P = 0.029).

Conclusions

The sequential combination of intracervical Foley catheter and intravaginal misoprostol for cervical ripening and induction of labor appears to be a safe and more effective method compared to intravaginal misoprostol in parturient at term with unfavorable cervices.
Literatur
1.
Zurück zum Zitat Crane JM, Butler B, Young DC, Hannah ME (2006) Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. Br J Obstet Gynaecol 113(12):1366–1376CrossRef Crane JM, Butler B, Young DC, Hannah ME (2006) Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. Br J Obstet Gynaecol 113(12):1366–1376CrossRef
2.
Zurück zum Zitat Owolabi AT, Kuti O, Ogunlola IO (2005) Randomised trial of intravaginal misoprostol and intracervical Foley catheter for cervical ripening and induction of labour. J Obstet Gynaecol 25(6):565–568PubMedCrossRef Owolabi AT, Kuti O, Ogunlola IO (2005) Randomised trial of intravaginal misoprostol and intracervical Foley catheter for cervical ripening and induction of labour. J Obstet Gynaecol 25(6):565–568PubMedCrossRef
3.
Zurück zum Zitat MacKenzie IZ, Burns E (1997) Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 1. Clinical outcome. Br J Obstet Gynaecol 104(9):1062–1067PubMedCrossRef MacKenzie IZ, Burns E (1997) Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 1. Clinical outcome. Br J Obstet Gynaecol 104(9):1062–1067PubMedCrossRef
4.
Zurück zum Zitat Helen HY, Leaseburge L, Khoury JC, Siddiqi TA, Spinnato JA, Sibai BM (2001) A comparison of various routes and dosages of misoprostol for cervical ripening and induction of labour. Am J Obstet Gynecol 185(4):911–915CrossRef Helen HY, Leaseburge L, Khoury JC, Siddiqi TA, Spinnato JA, Sibai BM (2001) A comparison of various routes and dosages of misoprostol for cervical ripening and induction of labour. Am J Obstet Gynecol 185(4):911–915CrossRef
5.
Zurück zum Zitat National Collaborating Centre for Women’s and Children’s Health. Induction of labour. London (UK): National Institute for Health and Clinical Excellence (NICE); 2008 July, 32 p (Clinical guideline; no. 70) National Collaborating Centre for Women’s and Children’s Health. Induction of labour. London (UK): National Institute for Health and Clinical Excellence (NICE); 2008 July, 32 p (Clinical guideline; no. 70)
6.
Zurück zum Zitat Delaney S, Shaffer BL, Cheng YW, Vargas J, Sparks TN, Paul K, Caughey AB (2010) Labor induction with a Foley balloon inflated to 30 mL compared with 60 mL: a randomized controlled trial. Obstet Gynecol 115(6):1239–1245PubMedCrossRef Delaney S, Shaffer BL, Cheng YW, Vargas J, Sparks TN, Paul K, Caughey AB (2010) Labor induction with a Foley balloon inflated to 30 mL compared with 60 mL: a randomized controlled trial. Obstet Gynecol 115(6):1239–1245PubMedCrossRef
7.
Zurück zum Zitat Abdellah MS, Hussien M, Aboalhassan A (2010) Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial. Arch Gynecol Obstet. doi:10.1007/s00404-010-1572-4 Abdellah MS, Hussien M, Aboalhassan A (2010) Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial. Arch Gynecol Obstet. doi:10.​1007/​s00404-010-1572-4
8.
Zurück zum Zitat Chung JH, Huang WH, Rumney PJ, Garite TJ, Nageotte MP (2003) A prospective randomized controlled trial that compared misoprostol, foley catheter, and combination misoprostol-foley catheter for labor induction. Am J Obstet Gynecol 189(4):1031–1035PubMedCrossRef Chung JH, Huang WH, Rumney PJ, Garite TJ, Nageotte MP (2003) A prospective randomized controlled trial that compared misoprostol, foley catheter, and combination misoprostol-foley catheter for labor induction. Am J Obstet Gynecol 189(4):1031–1035PubMedCrossRef
9.
Zurück zum Zitat Kashanian M, Akbarian AR, Fekrat M (2006) Cervical ripening and induction of labor with intravaginal misoprostol and foley catheter cervical traction. Int J Gynaecol Obstet 92(1):79–80PubMedCrossRef Kashanian M, Akbarian AR, Fekrat M (2006) Cervical ripening and induction of labor with intravaginal misoprostol and foley catheter cervical traction. Int J Gynaecol Obstet 92(1):79–80PubMedCrossRef
10.
Zurück zum Zitat Crane JM, Butler B, Young DC, Hannah ME (2006) Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. Br J Obstet Gynaecol 113(12):1366–1376CrossRef Crane JM, Butler B, Young DC, Hannah ME (2006) Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. Br J Obstet Gynaecol 113(12):1366–1376CrossRef
11.
Zurück zum Zitat Aziken M, Omo-Aghoja L, Okonofua F (2007) Perceptions and attitudes of pregnant women towards caesarean section in urban Nigeria. Acta Obstet Gynecol Scand 86(1):42–47PubMedCrossRef Aziken M, Omo-Aghoja L, Okonofua F (2007) Perceptions and attitudes of pregnant women towards caesarean section in urban Nigeria. Acta Obstet Gynecol Scand 86(1):42–47PubMedCrossRef
12.
Zurück zum Zitat Abramovici D, Goldwasser S, Mabie BC, Mercer BM, Goldwasser R, Sibai BM (1999) A randomized comparison of oral misoprostol versus Foley catheter and oxytocin for induction of labor at term. Am J obstet Gynecol 181(5 Pt 1):1108–1112PubMedCrossRef Abramovici D, Goldwasser S, Mabie BC, Mercer BM, Goldwasser R, Sibai BM (1999) A randomized comparison of oral misoprostol versus Foley catheter and oxytocin for induction of labor at term. Am J obstet Gynecol 181(5 Pt 1):1108–1112PubMedCrossRef
13.
Zurück zum Zitat Sciscione AC, Nguyen L, Manley J, Pollock M, Maas B, Colmorgen G (2001) A randomized comparison of transcervical Foley catheter to intravaginal misoprostol for preinduction cervical ripening. Obstet Gynecol 97(4):603–607PubMedCrossRef Sciscione AC, Nguyen L, Manley J, Pollock M, Maas B, Colmorgen G (2001) A randomized comparison of transcervical Foley catheter to intravaginal misoprostol for preinduction cervical ripening. Obstet Gynecol 97(4):603–607PubMedCrossRef
14.
Zurück zum Zitat Hill JB, Thigpen BD, Bofill JA, Magann E, Moore LE, Martin JN Jr (2009) A randomized clinical trial comparing vaginal misoprostol versus cervical foley plus oral misoprostol for cervical ripening and labor induction. Am J Perinatol 26(1):33–38PubMedCrossRef Hill JB, Thigpen BD, Bofill JA, Magann E, Moore LE, Martin JN Jr (2009) A randomized clinical trial comparing vaginal misoprostol versus cervical foley plus oral misoprostol for cervical ripening and labor induction. Am J Perinatol 26(1):33–38PubMedCrossRef
15.
Zurück zum Zitat Culver J, Strauss RA, Brody S, Dorman K, Timlin S, McMahon MJ (2004) A randomized trial comparing vaginal misoprostol versus foley catheter with concurrent oxytocin for labor induction in nulliparous women. Am J Perinatol 21(3):1CrossRef Culver J, Strauss RA, Brody S, Dorman K, Timlin S, McMahon MJ (2004) A randomized trial comparing vaginal misoprostol versus foley catheter with concurrent oxytocin for labor induction in nulliparous women. Am J Perinatol 21(3):1CrossRef
Metadaten
Titel
Induction of labor in prolonged pregnancy with unfavorable cervix: comparison of sequential intracervical Foley catheter–intravaginal misoprostol and intravaginal misoprostol alone
verfasst von
A. Babatunde Ande
C. Michael Ezeanochie
N. Biodun Olagbuji
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2094-4

Weitere Artikel der Ausgabe 4/2012

Archives of Gynecology and Obstetrics 4/2012 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.